Could pulmonary arterial hypertension patients be at a lower risk from severe COVID-19?

• Evelyn M. Horn,
• Murali Chakinala,
• Ronald Oudiz,
• Elizabeth Joseloff,
• Erika B. Rosenzweig

Affiliations

Evelyn M. Horn

Advanced Heart Failure & Pulmonary Vascular Disease Programs, Weill Cornell Medicine, New York Presbyterian Hospital, New York, USA

Murali Chakinala

Division of Pulmonary & Critical Care Medicine, Washington University in St Louis, St. Louis, MO, USA

Ronald Oudiz

David Geffen School of Medicine at UCLA Director, Liu Center for Pulmonary Hypertension, The Lundquist Institute Harbor, UCLA Medical Center, Santa Monica, CA, USA

Elizabeth Joseloff

Quality Care & Research Pulmonary Hypertension Association, Silver Spring, MD, USA

Erika B. Rosenzweig

Pulmonary Hypertension Comprehensive Care Center, Pediatrics and Medicine, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, USA